Erratum: Prognostic impact of iron parameters in patients undergoing allo-SCT (Bone Marrow Transplantation (2012) 47 (60-64) DOI: 10.1038/bmt.2011.13);Prognostic impact of iron parameters in patients undergoing allo-SCT

Bone Marrow Transplantation

Volumn 47, Issue 1, 2012, Pages 60-64

  Bazuave, G N ^a   Buser, A ^a   Gerull, S ^a   Tichelli, A ^a   Stern, M ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

allogeneic transplantation; ferritin; iron; transferrin saturation; TRM

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; FERRITIN; IRON; SOLUBLE TRANSFERRIN RECEPTOR; TRANSFERRIN; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; AREA UNDER THE CURVE; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; IRON BLOOD LEVEL; IRON OVERLOAD; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; MULTIPLE MYELOMA; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TRANSFERRIN BLOOD LEVEL; TRANSFERRIN SATURATION; TREATMENT OUTCOME;

EID: 84855739619     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2012.47     Document Type: Erratum

References (15)

1. Lichtman SM, Attivissimo L, Goldman IS, Schuster MW, Buchbinder A. Secondary hemochromatosis as a long-term complication of the treatment of hematologic malignancies. Am J Hematol 1999; 61: 262-264. (Pubitemid 29355024)
2. Majhail NS, Lazarus HM, Burns LJ. Iron overload in hematopoietic cell transplantation. Bone Marrow Transplant 2008; 41: 997-1003. (Pubitemid 352034174)
3. Carmine TC, Evans P, Bruchelt G, Evans R, Handgretinger R, Niethammer D et al. Presence of iron catalytic for free radical reactions in patients undergoing chemotherapy: implications for therapeutic management. Cancer Lett 1995; 94: 219-226.
4. Halliwell B, Gutteridge JM, Cross CE. Free radicals, antioxidants, and human disease: where are we now? J Lab Clin Med 1992; 119: 598-620.
5. Strasser SI, Kowdley KV, Sale GE, McDonald GB. Iron overload in bone marrow transplant recipients. Bone Marrow Transplant 1998; 22: 167-173. (Pubitemid 28375656)
6. Kanda J, Mizumoto C, Ichinohe T, Kawabata H, Saito T, Yamashita K et al. Pretransplant serum ferritin and C-reactive protein as predictive factors for early bacterial infection after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2011; 46: 208-216.
7. Beerenhout C, Bekers O, Kooman JP, van der Sande FM, Leunissen KM. A comparison between the soluble transferrin receptor, transferrin saturation and serum ferritin as markers of iron state in hemodialysis patients. Nephron 2002; 92: 32-35. (Pubitemid 34983872)
8. R'Zik S, Beguin Y. Serum soluble transferrin receptor concentration is an accurate estimate of the mass of tissue receptors. Exp Hematol 2001; 29: 677-685. (Pubitemid 32500368)
9. Gratwohl A, Stern M, Brand R, Apperley J, Baldomero H, de Witte T et al. Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis. Cancer 2009; 115: 4715-4726.
10. Centis F, Delfini C, Agostinelli F, Barbanti I, Annibali M, Lucarelli G. Correlation between soluble transferrin receptor and serum ferritin levels following bone marrow transplantation for thalassemia. Eur J Haematol 1995; 54: 329-333.
11. Baynes R, Bezwoda W, Bothwell T, Khan Q, Mansoor N. The non-immune inflammatory response: serial changes in plasma iron, iron-binding capacity, lactoferrin, ferritin and C-reactive protein. Scand J Clin Lab Invest 1986; 46: 695-704. (Pubitemid 17171522)
12. Altes A, Remacha AF, Sureda A, Martino R, Briones J, Canals C et al. Iron overload might increase transplant-related mortality in haematopoietic stem cell transplantation. Bone Marrow Transplant 2002; 29: 987-989. (Pubitemid 34845954)
13. Armand P, Kim HT, Cutler CS, Ho VT, Koreth J, Alyea EP et al. Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation. Blood 2007; 109: 4586-4588. (Pubitemid 46743431)
14. Sahlstedt L, Ebeling F, von Bonsdorff L, Parkkinen J, Ruutu T. Non-transferrin-bound iron during allogeneic stem cell transplantation. Br J Haematol 2001; 113: 836-838. (Pubitemid 32524411)
15. Pullarkat V. Objectives of iron chelation therapy in myelodysplastic syndromes: more than meets the eye? Blood 2009; 114: 5251-5255.